Manchester's Cancer Research UK Manchester Institute receives a substantial cash boost, marking a significant milestone in the city's cancer research landscape. This funding will not only strengthen the Institute's capabilities but also position Manchester as a global leader in the fight against cancer.
The additional £6 million annual investment from Cancer Research UK will be a game-changer. It will enable the recruitment of up to eight senior researchers, fostering collaboration and innovation in immunology, data science, and AI. These researchers will join a team of world-leading scientists, attracting even more talent to Manchester's burgeoning research community.
This investment extends beyond individual researchers. It will also support the development of the next generation of clinician scientists, in partnership with The Christie. By combining cutting-edge research with patient care, Manchester aims to revolutionize the cancer treatment landscape.
The Paterson building, home to the Cancer Research UK Manchester Institute, is strategically located near The Christie, facilitating rapid patient sample transfer. This proximity is crucial for efficient research and clinical trials, ensuring that Manchester's cancer research ecosystem remains at the forefront of innovation.
Professor Samra Turajlić, the newly appointed Director, expresses her enthusiasm for the funding boost. She emphasizes the Institute's expertise and the power of Manchester's cancer research partnerships. This investment, she believes, will attract top talent and accelerate progress in cancer research.
Sharon Quennell, a breast cancer survivor, shares her gratitude for the funding. As a former patient, she understands the importance of research and its impact on patients' lives. The extra investment, she says, is a testament to Manchester's commitment to cancer research.
The University of Manchester's Vice President and Dean of Biology, Medicine, and Health, Professor Ashley Blom, highlights the Institute's role in driving cancer research advancements. The increased funding will enable scientists to turn bold ideas into breakthroughs, shaping the future of cancer treatment.
Professor Fiona Blackhall, Director of Research and Innovation at The Christie, underscores Manchester's unique position. The collaboration between The Christie, the Cancer Research UK Manchester Institute, and The University of Manchester is a powerful force in cancer research, offering a comprehensive approach to cancer care.
Manchester's cancer research ecosystem is thriving, with around 45,800 cancer diagnoses in the North West annually. Cancer Research UK's generous support has doubled cancer survival rates in the UK over the past 50 years, making it the world's largest charitable funder of cancer research. This latest investment is a testament to Manchester's dedication to beating cancer and improving patient outcomes.
